Norwegian Biotech Startup Vitroscope Raises USD 7 Million

On 3 November, Trondheim-based Vitroscope announced USD 7 million in funding, including a USD 5 million seed round co-led by Cerberus Ventures and YZR Capital and USD 2 million in non-dilutive funding from the Research Council of Norway. The investment will support the commercial rollout of its live-tissue research platform and development of a higher-throughput system. The deal creates opportunities for life-science investors, laboratory suppliers and research partners. HPC can support startup market research, investor presentations and funding strategy.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.